Overview

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis

Status:
RECRUITING
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells Therapy
Phase:
PHASE3
Details
Lead Sponsor:
Wuxi Cellular Biopharmaceutical Group Ltd.
Treatments:
Hyaluronic Acid